ENERGI-F703 GEL

DRUG2 trials

Sponsors

Energenesis Biomedical Co., Ltd.

Conditions

Diabetes MellitusDiabetic Foot UlcerFoot UlcerVenous Leg UlcerWound

Phase 2

A Study to Evaluate ENERGI-F703 GEL in Venous Leg Ulcer

RecruitingNCT04078555

Energenesis Biomedical Co., Ltd.Venous Leg Ulcer

Start: 2022-07-26End: 2025-06-15Target: 80Updated: 2024-02-20

Phase 3

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

RecruitingNCT05930210

Energenesis Biomedical Co., Ltd.Diabetes Mellitus, Diabetic Foot Ulcer, Foot Ulcer +1

Start: 2023-05-30End: 2026-03-31Target: 230Updated: 2025-10-02